Litigation Details for Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc. (D. Del. 2015)
✉ Email this page to a colleague
Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc. (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-01-16 |
Court | District Court, D. Delaware | Date Terminated | 2016-08-08 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Parties | LABORATOIRE HRA PHARMA | ||
Patents | 8,426,392; 8,512,745; 8,735,380; 8,962,603; 9,283,233 | ||
Attorneys | Brian E. Farnan | ||
Firms | Farnan LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc.
Details for Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2015-01-15 | 1 | expiration of U.S. Patent Nos. 8,426,392 (the “’392 patent”); 8,512,745 (the “’745 patent”); and 8,735,380…Paragraph IV Certification Concerning U.S. Patent Nos. 8,426,392, 8,512,745 And 8,735,380” (“Notice Letter…This action is for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…,380 (the “’380 patent”) (collectively, the “patents-in-suit”). …. This civil action for patent infringement arises under the patent laws of the United States, including | External link to document | |
2015-01-15 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,426,392 B2; US 8,512,745 …2015 8 August 2016 1:15-cv-00045 830 Patent None District Court, D. Delaware | External link to document | |
2016-03-21 | 81 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,426,392 B2; US 8,512,745 …2015 8 August 2016 1:15-cv-00045 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |